Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3314938
Max Phase: Preclinical
Molecular Formula: C14H25N6O12P3
Molecular Weight: 562.31
Molecule Type: Small molecule
Associated Items:
ID: ALA3314938
Max Phase: Preclinical
Molecular Formula: C14H25N6O12P3
Molecular Weight: 562.31
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCC(C)c1nc2c(N)ncnc2n1[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)NP(=O)(O)O)[C@@H](O)[C@H]1O
Standard InChI: InChI=1S/C14H25N6O12P3/c1-3-6(2)12-18-8-11(15)16-5-17-13(8)20(12)14-10(22)9(21)7(31-14)4-30-35(28,29)32-34(26,27)19-33(23,24)25/h5-7,9-10,14,21-22H,3-4H2,1-2H3,(H,28,29)(H2,15,16,17)(H4,19,23,24,25,26,27)/t6?,7-,9-,10-,14-/m1/s1
Standard InChI Key: CPWOYWFVOIEYJA-JBJVTEQASA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 562.31 | Molecular Weight (Monoisotopic): 562.0743 | AlogP: -0.54 | #Rotatable Bonds: 10 |
Polar Surface Area: 281.93 | Molecular Species: ACID | HBA: 13 | HBD: 8 |
#RO5 Violations: 3 | HBA (Lipinski): 18 | HBD (Lipinski): 9 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 0.34 | CX Basic pKa: 4.82 | CX LogP: -4.15 | CX LogD: -10.77 |
Aromatic Rings: 2 | Heavy Atoms: 35 | QED Weighted: 0.17 | Np Likeness Score: 0.86 |
1. Gillerman I, Lecka J, Simhaev L, Munkonda MN, Fausther M, Martín-Satué M, Senderowitz H, Sévigny J, Fischer B.. (2014) 2-Hexylthio-β,γ-CH2-ATP is an effective and selective NTPDase2 inhibitor., 57 (14): [PMID:24972256] [10.1021/jm401933c] |
Source(1):